Ascendis Pharma
ASND
ASND
177 hedge funds and large institutions have $7.27B invested in Ascendis Pharma in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 63 increasing their positions, 61 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 171 → 177 (+6)
3% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 61
7% less capital invested
Capital invested by funds: $7.85B → $7.27B (-$582M)
Holders
177
Holding in Top 10
16
Calls
$48M
Puts
$31.1M
Top Buyers
| 1 | +$199M | |
| 2 | +$69.8M | |
| 3 | +$32M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$28.9M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$23.5M |
Top Sellers
| 1 | -$49.2M | |
| 2 | -$15.1M | |
| 3 | -$13.2M | |
| 4 |
SCM
Spyglass Capital Management
San Francisco,
California
|
-$12.7M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$10.8M |